Jacobs Levy Equity Management
MXCT icon

Jacobs Levy Equity Management’s MaxCyte MXCT Stock Holding History

Jacobs Levy Equity Management’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$545K Sell
776,224
-252,422
-25% -$236K ﹤0.01% 814
2025
Q4 		$1.59M Buy
+1,028,646
New +$1.64M 0.01% 620
2024
Q1 		– Sell
-251,001
Closed -$1.18M – 1013
2023
Q4 		$1.18M Buy
+251,001
New +$977K 0.01% 687

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $641M AUM 61.79% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $88.9M AUM

Jacobs Levy Equity Management's MXCT Position: Q1 2026 in Review

Jacobs Levy Equity Management reduced its MaxCyte (MXCT) stake by 25% in Q1 2026, selling an estimated $236K and leaving 776,224 shares worth $545K. The position accounts for ﹤0.01% of the portfolio, ranked #814.

Jacobs Levy Equity Management first reported a position in MXCT in Q4 2023 and has held it in 3 quarters since. The position peaked at $1.59M in Q4 2025. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Jacobs Levy Equity Management held 776,224 shares of MaxCyte worth $545K as of Q1 2026.
  • Jacobs Levy Equity Management sold 252,422 MaxCyte shares in Q1 2026, an estimated $236K.
  • MaxCyte made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q1 2026, its #814 holding.
  • Jacobs Levy Equity Management first reported a position in MaxCyte in Q4 2023 and has held it in 3 quarters since.
  • Jacobs Levy Equity Management's MaxCyte position peaked at $1.59M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2026, filed 15 May 2026.